Gyma works with multi-national companies in order to obtain licensing on their internal developments for the US market. These companies do not look to market their own products, and in most cases they do not manufacture. They are simply acting as a CRO, and look for partners to carry projects beyond formulation.
These types of formulations can be in any therapeutic category, and any type of delivery system. Further, they can range from a typical generic ANDA, to a 505b2, or an NDA. No matter which of these you choose, Gyma can assist you in finding the right partner.